576 related articles for article (PubMed ID: 28338787)
1. Total and Fetal Circulating Cell-Free DNA, Angiogenic, and Antiangiogenic Factors in Preeclampsia and HELLP Syndrome.
Muñoz-Hernández R; Medrano-Campillo P; Miranda ML; Macher HC; Praena-Fernández JM; Vallejo-Vaz AJ; Dominguez-Simeon MJ; Moreno-Luna R; Stiefel P
Am J Hypertens; 2017 Jul; 30(7):673-682. PubMed ID: 28338787
[TBL] [Abstract][Full Text] [Related]
2. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia.
Turpin CA; Sakyi SA; Owiredu WK; Ephraim RK; Anto EO
BMC Pregnancy Childbirth; 2015 Aug; 15():189. PubMed ID: 26303772
[TBL] [Abstract][Full Text] [Related]
3. Prediction of severe pre-eclampsia/HELLP syndrome by combination of sFlt-1, CT-pro-ET-1 and blood pressure: exploratory study.
Lind Malte A; Uldbjerg N; Wright D; Tørring N
Ultrasound Obstet Gynecol; 2018 Jun; 51(6):768-774. PubMed ID: 28643875
[TBL] [Abstract][Full Text] [Related]
4. Role of circulating cell-free DNA levels in patients with severe preeclampsia and HELLP syndrome.
Miranda ML; Macher HC; Muñoz-Hernández R; Vallejo-Vaz A; Moreno-Luna R; Villar J; Guerrero JM; Stiefel P
Am J Hypertens; 2013 Dec; 26(12):1377-80. PubMed ID: 24103646
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the diagnostic utility of the sFlt-1/PlGF ratio versus PlGF alone for the detection of preeclampsia/HELLP syndrome.
Stepan H; Hund M; Gencay M; Denk B; Dinkel C; Kaminski WE; Wieloch P; Semus B; Meloth T; Dröge LA; Verlohren S
Hypertens Pregnancy; 2016 Aug; 35(3):295-305. PubMed ID: 27028698
[TBL] [Abstract][Full Text] [Related]
6. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study.
Kim MY; Buyon JP; Guerra MM; Rana S; Zhang D; Laskin CA; Petri M; Lockshin MD; Sammaritano LR; Branch DW; Porter TF; Merrill JT; Stephenson MD; Gao Q; Karumanchi SA; Salmon JE
Am J Obstet Gynecol; 2016 Jan; 214(1):108.e1-108.e14. PubMed ID: 26432463
[TBL] [Abstract][Full Text] [Related]
7. The course of angiogenic factors in early- vs. late-onset preeclampsia and HELLP syndrome.
Schaarschmidt W; Rana S; Stepan H
J Perinat Med; 2013 Sep; 41(5):511-6. PubMed ID: 23612628
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population.
Kienast C; Moya W; Rodriguez O; Jijón A; Geipel A
J Matern Fetal Neonatal Med; 2016; 29(4):537-43. PubMed ID: 25708492
[TBL] [Abstract][Full Text] [Related]
9. Racial-ethnic differences in midtrimester maternal serum levels of angiogenic and antiangiogenic factors.
Yang J; Pearl M; DeLorenze GN; Romero R; Dong Z; Jelliffe-Pawlowski L; Currier R; Flessel M; Kharrazi M
Am J Obstet Gynecol; 2016 Sep; 215(3):359.e1-9. PubMed ID: 27073062
[TBL] [Abstract][Full Text] [Related]
10. The relationship between circulating tissue transglutaminase, soluble fms-like tyrosine kinase-1, soluble endoglin and vascular endothelial growth factor in pre-eclampsia.
Cheng M; He P; Fu J
J Hum Hypertens; 2016 Dec; 30(12):788-793. PubMed ID: 27169826
[TBL] [Abstract][Full Text] [Related]
11. PAPP-A levels of late pregnancy in preeclampsia and HELLP syndrome.
Atis A; Aydin Y; Basol E; Kaleli S; Turgay F; Goker N
Arch Gynecol Obstet; 2012 Jan; 285(1):45-9. PubMed ID: 21533533
[TBL] [Abstract][Full Text] [Related]
12. Angiogenic factors and acute-phase proteins in serum samples of preeclampsia and HELLP patients: a matched-pair analysis.
Reimer T; Rohrmann H; Stubert J; Pecks U; Glocker MO; Richter DU; Gerber B
J Matern Fetal Neonatal Med; 2013 Feb; 26(3):263-9. PubMed ID: 23020582
[TBL] [Abstract][Full Text] [Related]
13. Association of first-trimester angiogenic factors with placental histological findings in late-onset preeclampsia.
Triunfo S; Crovetto F; Crispi F; Rodriguez-Sureda V; Dominguez C; Nadal A; Peguero A; Gratacos E; Figueras F
Placenta; 2016 Jun; 42():44-50. PubMed ID: 27238713
[TBL] [Abstract][Full Text] [Related]
14. Circulating angiogenic factors are related to the severity of gestational hypertension and preeclampsia, and their adverse outcomes.
Leaños-Miranda A; Méndez-Aguilar F; Ramírez-Valenzuela KL; Serrano-Rodríguez M; Berumen-Lechuga G; Molina-Pérez CJ; Isordia-Salas I; Campos-Galicia I
Medicine (Baltimore); 2017 Jan; 96(4):e6005. PubMed ID: 28121958
[TBL] [Abstract][Full Text] [Related]
15. Soluble endoglin versus sFlt-1/PlGF ratio: detection of preeclampsia, HELLP syndrome, and FGR in a high-risk cohort.
Iannaccone A; Reisch B; Mavarani L; Darkwah Oppong M; Kimmig R; Mach P; Schmidt B; Köninger A; Gellhaus A
Hypertens Pregnancy; 2022; 41(3-4):159-172. PubMed ID: 35475405
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of preeclampsia and fetal growth restriction with the sFlt-1/PlGF ratio: Diagnostic accuracy of the automated immunoassay Kryptor®.
Dröge LA; Höller A; Ehrlich L; Verlohren S; Henrich W; Perschel FH
Pregnancy Hypertens; 2017 Apr; 8():31-36. PubMed ID: 28501276
[TBL] [Abstract][Full Text] [Related]
17. The role of serum uric acid as a prognostic indicator of the severity of maternal and fetal complications in hypertensive pregnancies.
Williams KP; Galerneau F
J Obstet Gynaecol Can; 2002 Aug; 24(8):628-32. PubMed ID: 12196841
[TBL] [Abstract][Full Text] [Related]
18. Angiogenic profiling in HELLP syndrome cases with or without hypertension and proteinuria.
Trottmann F; Baumann M; Amylidi-Mohr S; Surbek D; Risch L; Mosimann B; Raio L
Eur J Obstet Gynecol Reprod Biol; 2019 Dec; 243():93-96. PubMed ID: 31678761
[TBL] [Abstract][Full Text] [Related]
19. First-trimester serum soluble fms-like tyrosine kinase-1, free vascular endothelial growth factor, placental growth factor and uterine artery Doppler in preeclampsia.
Odibo AO; Rada CC; Cahill AG; Goetzinger KR; Tuuli MG; Odibo L; Macones GA; England SK
J Perinatol; 2013 Sep; 33(9):670-4. PubMed ID: 23558430
[TBL] [Abstract][Full Text] [Related]
20. Role of sFlt-1/PIGF ratio and uterine Doppler in pregnancies with chronic kidney disease suspected with Pre-eclampsia or HELLP syndrome.
Karge A; Beckert L; Moog P; Haller B; Ortiz JU; Lobmaier SM; Abel K; Flechsenhar S; Kuschel B; Graupner O
Pregnancy Hypertens; 2020 Oct; 22():160-166. PubMed ID: 32992124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
